Cargando…
Peptide binder design with inverse folding and protein structure prediction
The computational design of peptide binders towards a specific protein interface can aid diagnostic and therapeutic efforts. Here, we design peptide binders by combining the known structural space searched with Foldseek, the protein design method ESM-IF1, and AlphaFold2 (AF) in a joint framework. Fo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600234/ https://www.ncbi.nlm.nih.gov/pubmed/37880344 http://dx.doi.org/10.1038/s42004-023-01029-7 |
_version_ | 1785125946668351488 |
---|---|
author | Bryant, Patrick Elofsson, Arne |
author_facet | Bryant, Patrick Elofsson, Arne |
author_sort | Bryant, Patrick |
collection | PubMed |
description | The computational design of peptide binders towards a specific protein interface can aid diagnostic and therapeutic efforts. Here, we design peptide binders by combining the known structural space searched with Foldseek, the protein design method ESM-IF1, and AlphaFold2 (AF) in a joint framework. Foldseek generates backbone seeds for a modified version of ESM-IF1 adapted to protein complexes. The resulting sequences are evaluated with AF using an MSA representation for the receptor structure and a single sequence for the binder. We show that AF can accurately evaluate protein binders and that our bind score can select these (ROC AUC = 0.96 for the heterodimeric case). We find that designs created from seeds with more contacts per residue are more successful and tend to be short. There is a relationship between the sequence recovery in interface positions and the plDDT of the designs, where designs with ≥80% recovery have an average plDDT of 84 compared to 55 at 0%. Designed sequences have 60% higher median plDDT values towards intended receptors than non-intended ones. Successful binders (predicted interface RMSD ≤ 2 Å) are designed towards 185 (6.5%) heteromeric and 42 (3.6%) homomeric protein interfaces with ESM-IF1 compared with 18 (1.5%) using ProteinMPNN from 100 samples. |
format | Online Article Text |
id | pubmed-10600234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106002342023-10-27 Peptide binder design with inverse folding and protein structure prediction Bryant, Patrick Elofsson, Arne Commun Chem Article The computational design of peptide binders towards a specific protein interface can aid diagnostic and therapeutic efforts. Here, we design peptide binders by combining the known structural space searched with Foldseek, the protein design method ESM-IF1, and AlphaFold2 (AF) in a joint framework. Foldseek generates backbone seeds for a modified version of ESM-IF1 adapted to protein complexes. The resulting sequences are evaluated with AF using an MSA representation for the receptor structure and a single sequence for the binder. We show that AF can accurately evaluate protein binders and that our bind score can select these (ROC AUC = 0.96 for the heterodimeric case). We find that designs created from seeds with more contacts per residue are more successful and tend to be short. There is a relationship between the sequence recovery in interface positions and the plDDT of the designs, where designs with ≥80% recovery have an average plDDT of 84 compared to 55 at 0%. Designed sequences have 60% higher median plDDT values towards intended receptors than non-intended ones. Successful binders (predicted interface RMSD ≤ 2 Å) are designed towards 185 (6.5%) heteromeric and 42 (3.6%) homomeric protein interfaces with ESM-IF1 compared with 18 (1.5%) using ProteinMPNN from 100 samples. Nature Publishing Group UK 2023-10-25 /pmc/articles/PMC10600234/ /pubmed/37880344 http://dx.doi.org/10.1038/s42004-023-01029-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Bryant, Patrick Elofsson, Arne Peptide binder design with inverse folding and protein structure prediction |
title | Peptide binder design with inverse folding and protein structure prediction |
title_full | Peptide binder design with inverse folding and protein structure prediction |
title_fullStr | Peptide binder design with inverse folding and protein structure prediction |
title_full_unstemmed | Peptide binder design with inverse folding and protein structure prediction |
title_short | Peptide binder design with inverse folding and protein structure prediction |
title_sort | peptide binder design with inverse folding and protein structure prediction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600234/ https://www.ncbi.nlm.nih.gov/pubmed/37880344 http://dx.doi.org/10.1038/s42004-023-01029-7 |
work_keys_str_mv | AT bryantpatrick peptidebinderdesignwithinversefoldingandproteinstructureprediction AT elofssonarne peptidebinderdesignwithinversefoldingandproteinstructureprediction |